A review of air pollution as a driver of cardiovascular disease risk across the diabetes spectrum

Front Endocrinol (Lausanne). 2024 Apr 11:15:1321323. doi: 10.3389/fendo.2024.1321323. eCollection 2024.

Abstract

The prevalence of diabetes is estimated to reach almost 630 million cases worldwide by the year 2045; of current and projected cases, over 90% are type 2 diabetes. Air pollution exposure has been implicated in the onset and progression of diabetes. Increased exposure to fine particulate matter air pollution (PM2.5) is associated with increases in blood glucose and glycated hemoglobin (HbA1c) across the glycemic spectrum, including normoglycemia, prediabetes, and all forms of diabetes. Air pollution exposure is a driver of cardiovascular disease onset and exacerbation and can increase cardiovascular risk among those with diabetes. In this review, we summarize the literature describing the relationships between air pollution exposure, diabetes and cardiovascular disease, highlighting how airborne pollutants can disrupt glucose homeostasis. We discuss how air pollution and diabetes, via shared mechanisms leading to endothelial dysfunction, drive increased cardiovascular disease risk. We identify portable air cleaners as potentially useful tools to prevent adverse cardiovascular outcomes due to air pollution exposure across the diabetes spectrum, while emphasizing the need for further study in this particular population. Given the enormity of the health and financial impacts of air pollution exposure on patients with diabetes, a greater understanding of the interventions to reduce cardiovascular risk in this population is needed.

Keywords: air pollution; cardiovascular risk; environmental exposure; inflammation; oxidative stress; particulate matter; prevention.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Air Pollutants / adverse effects
  • Air Pollution* / adverse effects
  • Blood Glucose / metabolism
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / etiology
  • Diabetes Mellitus / epidemiology
  • Diabetes Mellitus / etiology
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / etiology
  • Environmental Exposure / adverse effects
  • Heart Disease Risk Factors
  • Humans
  • Particulate Matter / adverse effects
  • Risk Factors

Substances

  • Particulate Matter
  • Air Pollutants
  • Blood Glucose

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The work of the authors was supported by UL1TR001445 (LJB), Grant 2023-0214 from the Doris Duke Foundation (SW), NIDDK K08DK117064-04S1, NHLBI R01HL160891, NHLBI P01HL160470-1A (JA) and R01HL168597 (JN).